Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

Pensioners must boost the amount of folic acid they take to cut the risk of strokes and heart disease, according to scientists. They should take triple the daily dose of 200mg a day recommended by ...

Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei ...

Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045 , United States Department of Pharmacology, University of Colorado Anschutz ...

Novo Nordisk and The United Laboratories (TUL) have entered into an exclusive license agreement for UBT251, a triple receptor agonist targeting GLP-1, GIP, and glucagon, currently in early-stage ...